🚨One Week Only: Save 50% on a STAT+ subscription

Have your finger on the pulse of the biotech, pharma, and life science industries with a STAT+ subscription.

Log In  STAT+ 1 WEEK ONLY For a limited time: 50% off STAT+  Join the STAT+ community today and get trusted and authoritative coverage of the biotech, pharma, and life science industries delivered straight to your inbox.   For unlimited access to STAT, become a subscriber for less than $4 a week. Offer valid through August 11. SUBSCRIBE Recent top stories: 1   Vinay Prasad, a powerful FDA official, departs after controversy over rare disease drug By Lizzy Lawrence, Adam Feuerstein, and Matthew Herper 2   Trump administration reverses course, lifts pause on NIH grant awards By Angus Chen, Megan Molteni, and Anil Oza 3   Why Woebot, a pioneering therapy chatbot, shut down By Mario Aguilar STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us